PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel y_braun@rambam.health.gov.il.\', \'The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.\', \'Biochemistry Laboratory, Rambam Health Care Campus, Haifa, Israel.\', \'Bioinformatics, The Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Israel.\', \'B. Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-220503
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 34144967
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all